NGVT vs KWR vs JPM vs CBT vs FUL

For growth investors, JPMorgan Chase & Co.

(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -17. 0% for Ingevity Corporation (NGVT). Cabot Corporation (CBT) offers the better valuation at 14. 6x trailing P/E (13. 9x forward), making it the more compelling value choice. Analysts rate Ingevity Corporation (NGVT) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cabot Corporation (CBT) is the cheapest at 14.

6x versus H. B. Fuller Company at 23. 1x. On forward P/E, H. B. Fuller Company is actually cheaper at 13. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus H. B. Fuller Company's 4. 34x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -36. 1% for Quaker Chemical Corporation (KWR). Over 10 years, the gap is even starker: JPM returned +465. 8% versus FUL's +50. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

82β versus Quaker Chemical Corporation's 1. 36β — meaning KWR is approximately 66% more volatile than CBT relative to the S&P 500. On balance sheet safety, Quaker Chemical Corporation (KWR) carries a lower debt/equity ratio of 67% versus 42% for Ingevity Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), JPMorgan Chase & Co.

(JPM) is pulling ahead at 3. 3% versus -17. 0% for Ingevity Corporation (NGVT). On earnings-per-share growth, the picture is similar: Ingevity Corporation grew EPS 61. 1% year-over-year, compared to -102. 2% for Quaker Chemical Corporation. Over a 3-year CAGR, KWR leads at -1. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -14. 3% for Ingevity Corporation — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 9. 4% for KWR. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus H. B. Fuller Company's 4. 34x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, H. B. Fuller Company (FUL) trades at 13. 5x forward P/E versus 20. 6x for Quaker Chemical Corporation — 7. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KWR: 22. 4% to $176. 75.

In this comparison, CBT (2.

0% yield), JPM (1. 9% yield), FUL (1. 4% yield), KWR (1. 4% yield) pay a dividend. NGVT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Both have compounded well over 10 years (JPM: +465. 8%, NGVT: +111. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NGVT (Basic Materials) and KWR (Basic Materials) and JPM (Financial Services) and CBT (Basic Materials) and FUL (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NGVT is a small-cap quality compounder stock; KWR is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; CBT is a small-cap deep-value stock; FUL is a small-cap quality compounder stock. KWR, JPM, CBT, FUL pay a dividend while NGVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.